Position
Parallel Advisors, LLC in Intellia Therapeutics, Inc.
Back to the book · All holders of NTLA
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $2.37K$8.99 → $12.82
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 618 | $5.56K | — | — | — | 0.0% |
| Q1 2026 | 618 | $7.92K | $12.82 | $2.37K | $0 | 0.0% |